Bausch Health Companies Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 3 | $0.68 | $0.69 | $0.69 |
Q2 2024 | 3 | $0.88 | $0.88 | $0.88 |
Q3 2024 | 2 | $1.05 | $1.05 | $1.05 |
Q4 2024 | 7 | $0.90 | $1.36 | $1.14 |
Q1 2025 | 5 | $0.77 | $0.91 | $0.82 |
Q2 2025 | 4 | $1.04 | $1.09 | $1.06 |
Q3 2025 | 4 | $1.24 | $1.30 | $1.27 |
Q4 2025 | 4 | $1.29 | $1.35 | $1.32 |
Bausch Health Companies Inc. Earnings Date And Information
Bausch Health Companies Inc. last posted its earnings results on Wednesday, October 30th, 2024. The company reported $1.12 earnings per share for the quarter, topping analysts' consensus estimates of $1.03 by $0.09. The company had revenue of 2.51 B for the quarter and had revenue of 8.76 B for the year. Bausch Health Companies Inc. has generated $-2 earnings per share over the last year ($-1.62 diluted earnings per share) and currently has a price-to-earnings ratio of 13.54. Bausch Health Companies Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 19th, 2025 based on prior year's report dates.
Bausch Health Companies Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
10/30/2024 | Q3 2024 | -$0.23 | $2.48 B | $2.51 B | ||
08/01/2024 | Q2 2024 | $0.88 | $0.03 | -0.85 | $2.35 B | $2.40 B |
05/02/2024 | Q1 2024 | $0.75 | -$0.17 | -0.92 | $2.14 B | |
02/22/2024 | Q4 2023 | $1.02 | $1.08 | 0.06 | $2.41 B | |
11/02/2023 | Q3 2023 | $0.92 | -$1.03 | -1.95 | $2.17 B | $2.24 B |
08/03/2023 | Q2 2023 | $0.75 | $0.07 | -0.68 | $2.03 B | $2.17 B |
05/04/2023 | Q1 2023 | $0.75 | -$0.58 | -1.33 | $1.94 B | |
02/23/2023 | Q4 2022 | $0.92 | -$1.13 | -2.05 | $2.19 B | |
11/03/2022 | Q3 2022 | $0.92 | $1.10 | 0.18 | $1.99 B | $2.05 B |
08/09/2022 | Q2 2022 | $0.89 | -$0.38 | -1.27 | $2.04 B | $1.97 B |
05/10/2022 | Q1 2022 | $1.03 | -$0.18 | -1.21 | $1.92 B | |
02/23/2022 | Q4 2021 | $1.08 | $0.24 | -0.84 | $2.20 B | |
11/02/2021 | Q3 2021 | $1.07 | $0.66 | -0.41 | $2.12 B | $2.11 B |
08/03/2021 | Q2 2021 | $0.97 | -$1.66 | -2.63 | $2.11 B | $2.10 B |
05/04/2021 | Q1 2021 | $0.94 | -$1.71 | -2.65 | $2.03 B | |
02/24/2021 | Q4 2020 | $1.11 | -$0.43 | -1.54 | $2.21 B | |
11/03/2020 | Q3 2020 | $1.02 | $0.27 | -0.75 | $2.01 B | $2.14 B |
08/06/2020 | Q2 2020 | $0.66 | -$0.92 | -1.58 | $1.78 B | $1.66 B |
05/07/2020 | Q1 2020 | $0.90 | -$0.43 | -1.33 | $2.01 B | |
02/19/2020 | Q4 2019 | $1.15 | -$4.30 | -5.45 | $2.22 B |
Bausch Health Companies Inc. Earnings: Frequently Asked Questions
-
When is Bausch Health Companies Inc.'s earnings date?
Bausch Health Companies Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 19th, 2025 based off last year's report dates.
-
Did Bausch Health Companies Inc. beat their earnings estimates last quarter?
In the previous quarter, Bausch Health Companies Inc. (:BHC) reported $1.12 earnings per share (EPS) to beat the analysts' consensus estimate of $1.03 by $0.09.
-
How can I listen to Bausch Health Companies Inc.'s earnings conference call?
The conference call for Bausch Health Companies Inc.'s latest earnings report can be listened to online.
-
How can I read Bausch Health Companies Inc.'s conference call transcript?
The conference call transcript for Bausch Health Companies Inc.'s latest earnings report can be read online.
-
How much revenue does Bausch Health Companies Inc. generate each year?
Bausch Health Companies Inc. (:BHC) has a recorded annual revenue of $8.76 B.
-
How much profit does Bausch Health Companies Inc. generate each year?
Bausch Health Companies Inc. (:BHC) has a recorded net income of $8.76 B. Bausch Health Companies Inc. has generated $-1.62 earnings per share over the last four quarters.
-
What is Bausch Health Companies Inc.'s price-to-earnings ratio?
Bausch Health Companies Inc. (:BHC) has a price-to-earnings ratio of 13.54 and price/earnings-to-growth ratio is 0.02.